Phathom Pharmaceuticals Inc banner

Wall St Price Targets

PHAT Price Forecast
Based on 11 analysts

+244% Upside
from $6.23 today

Phathom Pharmaceuticals Inc (PHAT)’s 12-month stock price forecast through November 2027 has a consensus target of $21.42, implying 244% upside. The forecast is based on price targets from 11 Wall Street analysts.

PHAT Analyst Rating
Based on 11 analysts

avg. 4.64 of 5
Strong buy
8 73%
Buy
2 18%
Hold
1 9%
Sell
0 0%
Strong sell
0 0%

Analysts rate PHAT Strong buy, with 10 of 11 recommending Buy or Strong buy.

Phathom Pharmaceuticals Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PHAT's stock price target?
Price Target
21.42 USD

According to Wall Street analysts, the average 1-year price target for PHAT is 21.42 USD with a low forecast of 7.58 USD and a high forecast of 30.45 USD.

What is the Revenue forecast for Phathom Pharmaceuticals Inc?
Projected CAGR
24%

The compound annual growth rate for Revenue over the next 8 years is 24%.

What is the Gross Profit forecast for Phathom Pharmaceuticals Inc?
Projected CAGR
23%

The compound annual growth rate for Gross Profit over the next 8 years is 23%.

Back to Top